Neurostar® Effectiveness
Clinical trials have demonstrated the effectiveness of NeuroStar® TMS Therapy in treating patients who have not benefited from prior antidepressant medication. NeuroStar® TMS Therapy has the largest clinically studied data set of any TMS Treatment program, including over 900 participants. Clinical trials have shown that NeuroStar® may help to reduce or diminish symptoms of depression after 4 to 6 weeks of treatment.
The NeuroStar® Advanced Therapy’s Depression Outcomes Registry now has over 10,000 patient outcomes across 116 clinical practice sites, making it the largest outcomes registry in the world for Major Depressive Disorder (MDD). The registry’s latest findings showed that 73 percent of patients treated with NeuroStar experienced significant depression symptom improvement and 52 percent of patients achieved remission.
An Effective and Durable Option for Treating Major Depressive Disorder
In an independent, randomized, controlled trial funded by the National Institute of Mental Health, patients treated with NeuroStar® TMS Therapy were four times more likely to feel their depression symptoms significantly improve, compared to a control group of patients. 1
When studied over the course of a year:
- 1 in 2 TMS patients experienced significant improvement in their depression symptoms
- 1 in 3 experienced complete remission from their depression symptoms.2
Patients treated with the NeuroStar® TMS System also experienced significant improvement in anxiety and physical symptoms (such as appetite changes, aches and pains, and lack of energy) associated with depression.
NeuroStar TMS is the only TMS system with the durability of its effects estimated to last 12 or more months. After the end of a 4 to 6 week treatment period, only 1 in 3 NeuroStar® patients needed to come back for maintenance TMS sessions, or 'reintroduction' during this 12-month period. 3
NeuroStar TMS Therapy has not been studied in patients who have not received prior antidepressant treatment.
TMS+YOU is an online community and national patient advocacy site for TMS Therapy. Those considering Transcranial Magnetic Stimulation can connect with patients who have had the treatment to answer questions, share insights, and get the latest information.
References:
- Janicak PG, et al. (2010). Durability of Clinical Benefit with Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Major Depression: Assessment of Relapse During a 6-Month, Multisite, Open-Label Study. Brain Stimulation. 3(4):187-199. www.ncbi.nlm.nih.gov/pubmed/20965447
- Dunner DL, et al. (2014). A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation (TMS) for Patients with Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period. J Clin Psychiatry. 75(12):1394-1401. www.ncbi.nlm.nih.gov/pubmed/25271871
- Carpenter LL, et al. (2012). Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 29(7):587-96. https://doi.org/10.1002/da.21969
- Sackeim HA, et al. (2020). Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation. Journal of Affective Disorders. 277:65-74. https://doi.org/10.1016/j.jad.2020.08.005
Contact Upper East Side TMS
Phone:
212-737-7775
Office hours:
Monday through Friday 9 am - 5 PM.
Address:
122 East 82 Street Suite 1B
New York, NY 10028
In the Media:
- 07/18/2023 How Getting Pulsed by Magnets Let Me Feel Like Myself Again
- 05/30/2023 Severe depression treated with magnetic technology
- 05/23/2023 Depression treatment helped put a Houston man 'in the driver's seat' of his mental health
- 05/10/2023 Personalizing Transcranial Magnetic Stimulation for the treatment of depression
- 03/14/2023 Transcranial Magnetic Stimulation: A Treatment for Depression
Follow us on: